Ágnes Gyetvai

885 total citations
23 papers, 690 citations indexed

About

Ágnes Gyetvai is a scholar working on Immunology, Rheumatology and Molecular Biology. According to data from OpenAlex, Ágnes Gyetvai has authored 23 papers receiving a total of 690 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Rheumatology and 5 papers in Molecular Biology. Recurrent topics in Ágnes Gyetvai's work include Systemic Lupus Erythematosus Research (6 papers), Antifungal resistance and susceptibility (4 papers) and T-cell and B-cell Immunology (3 papers). Ágnes Gyetvai is often cited by papers focused on Systemic Lupus Erythematosus Research (6 papers), Antifungal resistance and susceptibility (4 papers) and T-cell and B-cell Immunology (3 papers). Ágnes Gyetvai collaborates with scholars based in Hungary, United Kingdom and Norway. Ágnes Gyetvai's co-authors include Zoltán Szekanecz, Anikó Kapitány, Gabriella Lakos, Péter Szodoray, Sándor Szántó, Zoltán Szabó, Gabriella Szűcs, Andrea Fekete, László Czirják and Béla Melegh and has published in prestigious journals such as International Journal of Molecular Sciences, Annals of the New York Academy of Sciences and Clinical Chemistry.

In The Last Decade

Ágnes Gyetvai

22 papers receiving 672 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ágnes Gyetvai Hungary 14 255 223 154 140 99 23 690
Rafael S. Grajewski Germany 15 174 0.7× 395 1.8× 137 0.9× 118 0.8× 46 0.5× 37 1.0k
Maida Wong United States 8 243 1.0× 408 1.8× 86 0.6× 112 0.8× 68 0.7× 12 741
Masataka Satoh Japan 14 199 0.8× 338 1.5× 80 0.5× 135 1.0× 48 0.5× 37 790
Huaxiang Wu China 18 478 1.9× 252 1.1× 108 0.7× 266 1.9× 54 0.5× 70 1.0k
Pascale Chrétien France 16 193 0.8× 128 0.6× 264 1.7× 167 1.2× 58 0.6× 46 1.1k
Conleth Feighery Ireland 16 372 1.5× 297 1.3× 174 1.1× 130 0.9× 143 1.4× 24 995
Asuka Inoue Japan 17 211 0.8× 331 1.5× 67 0.4× 169 1.2× 72 0.7× 41 691
Éric Assier France 18 224 0.9× 569 2.6× 79 0.5× 227 1.6× 111 1.1× 32 1.0k
Chaokui Wang China 17 250 1.0× 210 0.9× 96 0.6× 251 1.8× 25 0.3× 33 844
Gaëlle Clavel France 18 299 1.2× 186 0.8× 64 0.4× 157 1.1× 55 0.6× 50 759

Countries citing papers authored by Ágnes Gyetvai

Since Specialization
Citations

This map shows the geographic impact of Ágnes Gyetvai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ágnes Gyetvai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ágnes Gyetvai more than expected).

Fields of papers citing papers by Ágnes Gyetvai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ágnes Gyetvai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ágnes Gyetvai. The network helps show where Ágnes Gyetvai may publish in the future.

Co-authorship network of co-authors of Ágnes Gyetvai

This figure shows the co-authorship network connecting the top 25 collaborators of Ágnes Gyetvai. A scholar is included among the top collaborators of Ágnes Gyetvai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ágnes Gyetvai. Ágnes Gyetvai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gyetvai, Ágnes, et al.. (2025). Anifrolumab Attenuates Follicular Helper T Cell Activation in Patients with Systemic Lupus Erythematosus. International Journal of Molecular Sciences. 26(15). 7397–7397. 1 indexed citations
2.
Gyetvai, Ágnes, Attila Bácsi, Attila Oláh, et al.. (2022). TRPV4 Activation Increases the Expression of CD207 (Langerin) of Monocyte-Derived Langerhans Cells without Affecting their Maturation. Journal of Investigative Dermatology. 143(5). 801–811.e10. 4 indexed citations
3.
Balogh, László, Krisztina Szabó, József Márton Pucsok, et al.. (2022). The Effect of Aerobic Exercise and Low-Impact Pilates Workout on the Adaptive Immune System. Journal of Clinical Medicine. 11(22). 6814–6814. 10 indexed citations
4.
Gáll, Tamás, Abolfazl Zarjou, Zoltán Hendrik, et al.. (2020). Ferryl Hemoglobin Inhibits Osteoclastic Differentiation of Macrophages in Hemorrhaged Atherosclerotic Plaques. Oxidative Medicine and Cellular Longevity. 2020. 1–17. 15 indexed citations
5.
Potor, László, Péter Nagy, Gábor Méhes, et al.. (2018). Hydrogen Sulfide Abrogates Hemoglobin‐Lipid Interaction in Atherosclerotic Lesion. Oxidative Medicine and Cellular Longevity. 2018(1). 3812568–3812568. 35 indexed citations
6.
Balogh, Enikő, Béla Nagy, Ágnes Gyetvai, et al.. (2016). Impaired Immunosuppressive Effect of Bronchoalveolar Mesenchymal Stem Cells in Hypersensitivity Pneumonitis: Preliminary Findings. Cytometry Part B Clinical Cytometry. 94(2). 363–368. 3 indexed citations
7.
Róka, R, P. Kiss, Ágnes Gyetvai, et al.. (2014). The effect of combined long term Aspirin and proton pump inhibitor therapy on the histological progression of Barrett's metaplasia. Zeitschrift für Gastroenterologie. 52(5). 1 indexed citations
8.
Váróczy, László, Erika Zilahi, Ágnes Gyetvai, et al.. (2011). Fc-Gamma-Receptor IIIa Polymorphism and Gene Expression Profile Do Not Predict the Prognosis in Diffuse Large B-cell Lymphoma Treated with R-CHOP Protocol. Pathology & Oncology Research. 18(1). 43–48. 19 indexed citations
9.
Griger, Zoltán, Balázs István Tóth, S. Baráth, et al.. (2011). Different Effects of Bortezomib on the Expressions of Various Protein Kinase C Isoenzymes in T Cells of Patients with Systemic Lupus Erythematosus and in Jurkat Cells. Scandinavian Journal of Immunology. 75(2). 243–248. 7 indexed citations
10.
Chinoy, Hector, Paul New, Erika Zilahi, et al.. (2011). Interaction of HLA-DRB1*03 and smoking for the development of anti-Jo-1 antibodies in adult idiopathic inflammatory myopathies: a European-wide case study. Annals of the Rheumatic Diseases. 71(6). 961–965. 85 indexed citations
11.
Tumpek, Judit, et al.. (2010). An unusual association: anti-Jo1 and anti-SRP antibodies in the serum of a patient with polymyositis. Clinical Rheumatology. 29(7). 811–814. 21 indexed citations
12.
Kapitány, Anikó, Tünde Tarr, Ágnes Gyetvai, et al.. (2009). Human Leukocyte Antigen‐DRB1 and ‐DQB1 Genotyping in Lupus Patients with and without Antiphospholipid Syndrome. Annals of the New York Academy of Sciences. 1173(1). 545–551. 12 indexed citations
13.
Szodoray, Péter, Zoltán Szabó, Anikó Kapitány, et al.. (2009). Anti-citrullinated protein/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis. Autoimmunity Reviews. 9(3). 140–143. 150 indexed citations
14.
Gyetvai, Ágnes, Zoltán Szekanecz, Lilla Soós, et al.. (2009). New classification of the shared epitope in rheumatoid arthritis: impact on the production of various anti-citrullinated protein antibodies. Lara D. Veeken. 49(1). 25–33. 22 indexed citations
15.
Fekete, Andrea, Tamás Emri, Ágnes Gyetvai, et al.. (2008). Physiological and morphological characterization of tert ‐butylhydroperoxide tolerant Candida albicans mutants. Journal of Basic Microbiology. 48(6). 480–487. 9 indexed citations
16.
Faragó, Bernadett, Katalin Komlósi, Gergely Nagy, et al.. (2008). Protein tyrosine phosphatase gene C1858T allele confers risk for rheumatoid arthritis in Hungarian subjects. Rheumatology International. 29(7). 793–796. 25 indexed citations
17.
18.
Faragó, Bernadett, Lili Magyari, Enikő Sáfrány, et al.. (2007). Functional variants of interleukin-23 receptor gene confer risk for rheumatoid arthritis but not for systemic sclerosis. Annals of the Rheumatic Diseases. 67(2). 248–250. 112 indexed citations
19.
Gyetvai, Ágnes, et al.. (2006). Lovastatin possesses a fungistatic effect againstCandida albicans, but does not trigger apoptosis in this opportunistic human pathogen. FEMS Yeast Research. 6(8). 1140–1148. 46 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rafael S. Grajewski Breakdown of academic impact, for papers by Maida Wong Breakdown of academic impact, for papers by Masataka Satoh Breakdown of academic impact, for papers by Huaxiang Wu Breakdown of academic impact, for papers by Pascale Chrétien Breakdown of academic impact, for papers by Conleth Feighery Breakdown of academic impact, for papers by Asuka Inoue Breakdown of academic impact, for papers by Éric Assier Breakdown of academic impact, for papers by Chaokui Wang Breakdown of academic impact, for papers by Gaëlle Clavel
Rankless by CCL
2026